Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |